Compare iShares MSCI Hong Kong ETF (EWH) vs Humana Inc (HUM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI Hong Kong ETF vs Humana Inc — how do they compare? iShares MSCI Hong Kong ETF trades at $22.46, while Humana Inc trades at $388.05 (market cap $44.77B). The key difference: Humana Inc pays a 0.95% dividend while iShares MSCI Hong Kong ETF pays none, and Humana Inc is trading nearer its 52-week high, iShares MSCI Hong Kong ETF nearer its low. Which is the better fit depends on your goals.
| EWH | HUM | |
|---|---|---|
Sector | Broad Market / Factor | Health |
52-Week High | $24.55 | $409.42 |
52-Week Low | $20.66 | $163.67 |
Market Cap | — | $44.77B |
Enterprise Value | — | $52.12B |
Dividend Yield | — | 0.95% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EWH trades at $22.45, down 1.54% on the day, with a bearish technical signal from moving averages and neutral oscillators. Recent news highlights the Hang Seng Index's rebound and potential golden cross formation, driven by technology stock recoveries. The ETF shows no available fundamental ratios in the provided data, but tracks Hong Kong equities, with a dividend scheduled for June 2026.
Outlook hinges on Hong Kong market performance and tech sector momentum. Risks include Asian market volatility and geopolitical factors. Analyst sentiment is mixed, with some bullish on Hong Kong over Korea, while technicals suggest caution near support at $22.
Humana (HUM) trades at $388.96, up 0.9% with a neutral technical signal. The stock shows strong revenue growth reaching $129.7B in 2025 but faces margin compression with net income margin declining to 0.88%. Recent earnings beat expectations for three consecutive quarters, while analyst consensus targets $409.93. The company maintains solid cash flow generation and recently announced key leadership appointments to strengthen its Medicaid business.
Humana presents a mixed outlook with robust revenue expansion offset by margin pressures. Investment opportunity lies in Medicare Advantage growth and cost reduction initiatives, while risks include competitive pressures and regulatory changes in healthcare. Wall Street maintains cautious optimism with 39% buy ratings amid margin recovery challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About iShares MSCI Hong Kong ETF
EWH tracks the MSCI Hong Kong 25/50 Index, providing broad exposure to large and mid-cap companies listed in Hong Kong. It focuses on the established pillars of the local economy, with heavy weightings in financials, real estate, and utilities, serving as a single-country diversification tool.
Read more on EWH →About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →
